tirzepatide children π¨ Diabetes News Update for Families π¨ Big update in pediatric diabetes care π Mounjaro (tirzepatide) is now approved for and adolescents ages 10 and older with type 2 diabetes. This Lilly's Mounjaro scores in Type
Description
Heres a recap: Tirzepatide is available in six dosage strengths ranging from 2.5 mg to 15 mg
Related Articles This article supports our Medical Weight Loss service page
Signs you might need less than 50 units Persistent nausea lasting more than 3-4 days after injection
Reconstituted solution keeps for ~28 days refrigerated
People who lost weight on Tirzepatide were split into 3 groups: stay on the full dose, drop to 5 mg, or switch to placebo
